LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article ; Online: Natural killer cells kill extracellular Pseudomonas aeruginosa using contact-dependent release of granzymes B and H.

    David D Feehan / Khusraw Jamil / Maria J Polyak / Henry Ogbomo / Mark Hasell / Shu Shun Li / Richard F Xiang / Michael Parkins / Joseph A Trapani / Joe J Harrison / Christopher H Mody

    PLoS Pathogens, Vol 18, Iss 2, p e

    2022  Volume 1010325

    Abstract: Pseudomonas aeruginosa is an opportunistic pathogen that often infects individuals with the genetic disease cystic fibrosis, and contributes to airway blockage and loss of lung function. Natural killer (NK) cells are cytotoxic, granular lymphocytes that ... ...

    Abstract Pseudomonas aeruginosa is an opportunistic pathogen that often infects individuals with the genetic disease cystic fibrosis, and contributes to airway blockage and loss of lung function. Natural killer (NK) cells are cytotoxic, granular lymphocytes that are part of the innate immune system. NK cell secretory granules contain the cytolytic proteins granulysin, perforin and granzymes. In addition to their cytotoxic effects on cancer and virally infected cells, NK cells have been shown to play a role in an innate defense against microbes, including bacteria. However, it is not known if NK cells kill extracellular P. aeruginosa or how bacterial killing might occur at the molecular level. Here we show that NK cells directly kill extracellular P. aeruginosa using NK effector molecules. Live cell imaging of a co-culture of YT cells, a human NK cell line, and GFP-expressing P. aeruginosa in the presence of the viability dye propidium iodide demonstrated that YT cell killing of P. aeruginosa is contact-dependent. CRISPR knockout of granulysin or perforin in YT cells had no significant effect on YT cell killing of P. aeruginosa. Pre-treatment of YT and NK cells with the serine protease inhibitor 3,4-dichloroisocoumarin (DCI) to inhibit all granzymes, resulted in an inhibition of killing. Although singular CRISPR knockout of granzyme B or H had no effect, knockout of both in YT cells completely abrogated killing of P. aeruginosa in comparison to wild type YT cell controls. Nitrocefin assays suggest that the bacterial membrane is damaged. Inhibition of killing by antioxidants suggest that ROS are required for the bactericidal mode-of-action. Taken together, these results identify that NK cells kill P. aeruginosa through a membrane damaging, contact-dependent process that requires granzyme induced ROS production, and moreover, that granzyme B and H are redundant in this killing process.
    Keywords Immunologic diseases. Allergy ; RC581-607 ; Biology (General) ; QH301-705.5
    Subject code 612 ; 572
    Language English
    Publishing date 2022-02-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Enhancing the Potential of Immunotherapy in Paediatric Sarcomas

    Emmy D. G. Fleuren / Rachael L. Terry / Deborah Meyran / Natacha Omer / Joseph A. Trapani / Michelle Haber / Paul J. Neeson / Paul G. Ekert

    Biomedicines, Vol 9, Iss 1798, p

    Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors

    2021  Volume 1798

    Abstract: Despite aggressive surgery, chemotherapy, and radiotherapy, survival of children and adolescents and young adults (AYAs) with sarcoma has not improved significantly in the past four decades. Immune checkpoint inhibitors (ICIs) are an exciting type of ... ...

    Abstract Despite aggressive surgery, chemotherapy, and radiotherapy, survival of children and adolescents and young adults (AYAs) with sarcoma has not improved significantly in the past four decades. Immune checkpoint inhibitors (ICIs) are an exciting type of immunotherapy that offer new opportunities for the treatment of paediatric and AYA sarcomas. However, to date, most children do not derive a benefit from this type of treatment as a monotherapy. The immunosuppressive tumour microenvironment is a major barrier limiting their efficacy. Combinations of ICIs, such as anti-PD-1 therapy, with targeted molecular therapies that have immunomodulatory properties may be the key to breaking through immunosuppressive barriers and improving patient outcomes. Preclinical studies have indicated that several receptor tyrosine kinase inhibitors (RTKi) can alter the tumour microenvironment and boost the efficacy of anti-PD-1 therapy. A number of these combinations have entered phase-1/2 clinical trials, mostly in adults, and in most instances have shown efficacy with manageable side-effects. In this review, we discuss the status of ICI therapy in paediatric and AYA sarcomas and the rationale for co-treatment with RTKis. We highlight new opportunities for the integration of ICI therapy with RTK inhibitors, to improve outcomes for children with sarcoma.
    Keywords paediatric and AYA sarcoma ; immunotherapy ; immune checkpoint inhibitors ; receptor tyrosine kinase inhibitors ; Biology (General) ; QH301-705.5
    Subject code 616
    Language English
    Publishing date 2021-11-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance

    Mohamed Fareh / Wei Zhao / Wenxin Hu / Joshua M. L. Casan / Amit Kumar / Jori Symons / Jennifer M. Zerbato / Danielle Fong / Ilia Voskoboinik / Paul G. Ekert / Rajeev Rudraraju / Damian F. J. Purcell / Sharon R. Lewin / Joseph A. Trapani

    Nature Communications, Vol 12, Iss 1, Pp 1-

    2021  Volume 16

    Abstract: Cas13b can be harnessed to target and degrade RNA transcripts inside a cellular environment. Here the authors reprogram Cas13b to target SARSCoV-2 transcripts in infected mammalian cells and reveal its resilience to variants thanks to single mismatch ... ...

    Abstract Cas13b can be harnessed to target and degrade RNA transcripts inside a cellular environment. Here the authors reprogram Cas13b to target SARSCoV-2 transcripts in infected mammalian cells and reveal its resilience to variants thanks to single mismatch tolerance.
    Keywords Science ; Q
    Language English
    Publishing date 2021-07-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Lipid order and charge protect killer T cells from accidental death

    Jesse A. Rudd-Schmidt / Adrian W. Hodel / Tahereh Noori / Jamie A. Lopez / Hyun-Jung Cho / Sandra Verschoor / Annette Ciccone / Joseph A. Trapani / Bart W. Hoogenboom / Ilia Voskoboinik

    Nature Communications, Vol 10, Iss 1, Pp 1-

    2019  Volume 13

    Abstract: Cytotoxic T lymphocytes (CTLs) eliminate virus-infected and cancerous cells by secreting the pore-forming protein (perforin) and pro-apoptotic serine proteases (granzymes). Here authors show that two mechanisms protect the membranes of CTLs from ... ...

    Abstract Cytotoxic T lymphocytes (CTLs) eliminate virus-infected and cancerous cells by secreting the pore-forming protein (perforin) and pro-apoptotic serine proteases (granzymes). Here authors show that two mechanisms protect the membranes of CTLs from disruption by perforin and granzymes.
    Keywords Science ; Q
    Language English
    Publishing date 2019-11-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Lipid order and charge protect killer T cells from accidental death

    Jesse A. Rudd-Schmidt / Adrian W. Hodel / Tahereh Noori / Jamie A. Lopez / Hyun-Jung Cho / Sandra Verschoor / Annette Ciccone / Joseph A. Trapani / Bart W. Hoogenboom / Ilia Voskoboinik

    Nature Communications, Vol 10, Iss 1, Pp 1-

    2019  Volume 13

    Abstract: Cytotoxic T lymphocytes (CTLs) eliminate virus-infected and cancerous cells by secreting the pore-forming protein (perforin) and pro-apoptotic serine proteases (granzymes). Here authors show that two mechanisms protect the membranes of CTLs from ... ...

    Abstract Cytotoxic T lymphocytes (CTLs) eliminate virus-infected and cancerous cells by secreting the pore-forming protein (perforin) and pro-apoptotic serine proteases (granzymes). Here authors show that two mechanisms protect the membranes of CTLs from disruption by perforin and granzymes.
    Keywords Science ; Q
    Language English
    Publishing date 2019-11-01T00:00:00Z
    Publisher Nature Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article: Cloning and characterising an unusual perforin from chicken (Gallus gallus)

    D’Angelo, Michael E / Arash Arjomand / Joseph A. Trapani / Phillip I. Bird

    Developmental and comparative immunology. 2013 Oct., v. 41, no. 2

    2013  

    Abstract: In mammals the 67kDa pore-forming protein perforin is essential to the granule exocytosis pathway used by cytotoxic lymphocytes to eliminate virally infected and malignant cells. There is indirect evidence that this pathway exists in lower vertebrates ... ...

    Abstract In mammals the 67kDa pore-forming protein perforin is essential to the granule exocytosis pathway used by cytotoxic lymphocytes to eliminate virally infected and malignant cells. There is indirect evidence that this pathway exists in lower vertebrates such as teleost fish and birds, although in genome databases for the chicken and other bird species the perforin gene is incomplete and no full length expressed sequence tag has been reported. We present here the full gene and transcript sequence of chicken perforin. The inferred protein product contains an extended C-terminus that is at least 90 amino acids longer than any mammalian perforin, which is also evident in partial genomic sequences from other birds. To determine whether this extension is present in the translated protein, we raised two polyclonal antisera. The antisera identified a protein of just less than 80kDa in both transfected COS-1 cells and concanavalin A stimulated chicken splenocytes, indicating that the extended C-terminus is present in the mature protein. Our findings confirm that perforin exists in birds, and show that it is considerably longer than perforin of non-avian vertebrates.
    Keywords amino acids ; antiserum ; chickens ; cytotoxicity ; databases ; exocytosis ; expressed sequence tags ; fish ; Gallus gallus ; genes ; lymphocytes ; mammals ; messenger RNA ; splenocytes
    Language English
    Dates of publication 2013-10
    Size p. 105-109.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 752411-0
    ISSN 1879-0089 ; 0145-305X
    ISSN (online) 1879-0089
    ISSN 0145-305X
    DOI 10.1016/j.dci.2013.05.003
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer

    Chelsea Mayoh / Andrew J. Gifford / Rachael Terry / Loretta M. S. Lau / Marie Wong / Padmashree Rao / Tyler Shai-Hee / Federica Saletta / Dong-Anh Khuong-Quang / Vicky Qin / Marion K. Mateos / Deborah Meyran / Katherine E. Miller / Aysen Yuksel / Emily V. A. Mould / Rachel Bowen-James / Dinisha Govender / Akanksha Senapati / Nataliya Zhukova /
    Natacha Omer / Hetal Dholaria / Frank Alvaro / Heather Tapp / Yonatan Diamond / Luciano Dalla Pozza / Andrew S. Moore / Wayne Nicholls / Nicholas G. Gottardo / Geoffrey McCowage / Jordan R. Hansford / Seong-Lin Khaw / Paul J. Wood / Daniel Catchpoole / Catherine E. Cottrell / Elaine R. Mardis / Glenn M. Marshall / Vanessa Tyrrell / Michelle Haber / David S. Ziegler / Orazio Vittorio / Joseph A. Trapani / Mark J. Cowley / Paul J. Neeson / Paul G. Ekert

    Genome Medicine, Vol 15, Iss 1, Pp 1-

    2023  Volume 18

    Abstract: Abstract Background Molecular profiling of the tumour immune microenvironment (TIME) has enabled the rational choice of immunotherapies in some adult cancers. In contrast, the TIME of paediatric cancers is relatively unexplored. We speculated that a more ...

    Abstract Abstract Background Molecular profiling of the tumour immune microenvironment (TIME) has enabled the rational choice of immunotherapies in some adult cancers. In contrast, the TIME of paediatric cancers is relatively unexplored. We speculated that a more refined appreciation of the TIME in childhood cancers, rather than a reliance on commonly used biomarkers such as tumour mutation burden (TMB), neoantigen load and PD-L1 expression, is an essential prerequisite for improved immunotherapies in childhood solid cancers. Methods We combined immunohistochemistry (IHC) with RNA sequencing and whole-genome sequencing across a diverse spectrum of high-risk paediatric cancers to develop an alternative, expression-based signature associated with CD8+ T-cell infiltration of the TIME. Furthermore, we explored transcriptional features of immune archetypes and T-cell receptor sequencing diversity, assessed the relationship between CD8+ and CD4+ abundance by IHC and deconvolution predictions and assessed the common adult biomarkers such as neoantigen load and TMB. Results A novel 15-gene immune signature, Immune Paediatric Signature Score (IPASS), was identified. Using this signature, we estimate up to 31% of high-risk cancers harbour infiltrating T-cells. In addition, we showed that PD-L1 protein expression is poorly correlated with PD-L1 RNA expression and TMB and neoantigen load are not predictive of T-cell infiltration in paediatrics. Furthermore, deconvolution algorithms are only weakly correlated with IHC measurements of T-cells. Conclusions Our data provides new insights into the variable immune-suppressive mechanisms dampening responses in paediatric solid cancers. Effective immune-based interventions in high-risk paediatric cancer will require individualised analysis of the TIME.
    Keywords Paediatric cancer ; Tumour immune microenvironment ; T-cell infiltration ; Biomarkers ; Transcriptome signature ; Medicine ; R ; Genetics ; QH426-470
    Subject code 616
    Language English
    Publishing date 2023-04-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance

    Mayura V. Wagle / Stephin J. Vervoort / Madison J. Kelly / Willem Van Der Byl / Timothy J. Peters / Ben P. Martin / Luciano G. Martelotto / Simone Nüssing / Kelly M. Ramsbottom / James R. Torpy / Deborah Knight / Sinead Reading / Kevin Thia / Lisa A. Miosge / Debbie R. Howard / Renee Gloury / Sarah S. Gabriel / Daniel T. Utzschneider / Jane Oliaro /
    Jonathan D. Powell / Fabio Luciani / Joseph A. Trapani / Ricky W. Johnstone / Axel Kallies / Christopher C. Goodnow / Ian A. Parish

    Nature Communications, Vol 12, Iss 1, Pp 1-

    2021  Volume 15

    Abstract: Exhausted T cells arise when chronic activation triggers functional defects. Here the authors show that chronic antigenic stimulation in both tumour and infection models induces the expression of EGR2, which drives and stabilises exhausted cell ... ...

    Abstract Exhausted T cells arise when chronic activation triggers functional defects. Here the authors show that chronic antigenic stimulation in both tumour and infection models induces the expression of EGR2, which drives and stabilises exhausted cell epigenetic and transcriptional identity.
    Keywords Science ; Q
    Language English
    Publishing date 2021-05-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer

    Sathana Dushyanthen / Zhi Ling Teo / Franco Caramia / Peter Savas / Christopher P. Mintoff / Balaji Virassamy / Melissa A. Henderson / Stephen J. Luen / Mariam Mansour / Michael H. Kershaw / Joseph A. Trapani / Paul J. Neeson / Roberto Salgado / Grant A. McArthur / Justin M. Balko / Paul A. Beavis / Phillip K. Darcy / Sherene Loi

    Nature Communications, Vol 8, Iss 1, Pp 1-

    2017  Volume 18

    Abstract: MEK inhibition in breast cancer is associated with increased tumour infiltrating lymphocytes (TILs), however, MAPK activity is required for T cells function. Here the authors show that TILs activity following MEK inhibition can be enhanced by agonist ... ...

    Abstract MEK inhibition in breast cancer is associated with increased tumour infiltrating lymphocytes (TILs), however, MAPK activity is required for T cells function. Here the authors show that TILs activity following MEK inhibition can be enhanced by agonist immunotherapy resulting in synergic therapeutic effects.
    Keywords Science ; Q
    Language English
    Publishing date 2017-09-01T00:00:00Z
    Publisher Nature Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer

    Sathana Dushyanthen / Zhi Ling Teo / Franco Caramia / Peter Savas / Christopher P. Mintoff / Balaji Virassamy / Melissa A. Henderson / Stephen J. Luen / Mariam Mansour / Michael H. Kershaw / Joseph A. Trapani / Paul J. Neeson / Roberto Salgado / Grant A. McArthur / Justin M. Balko / Paul A. Beavis / Phillip K. Darcy / Sherene Loi

    Nature Communications, Vol 8, Iss 1, Pp 1-

    2017  Volume 18

    Abstract: MEK inhibition in breast cancer is associated with increased tumour infiltrating lymphocytes (TILs), however, MAPK activity is required for T cells function. Here the authors show that TILs activity following MEK inhibition can be enhanced by agonist ... ...

    Abstract MEK inhibition in breast cancer is associated with increased tumour infiltrating lymphocytes (TILs), however, MAPK activity is required for T cells function. Here the authors show that TILs activity following MEK inhibition can be enhanced by agonist immunotherapy resulting in synergic therapeutic effects.
    Keywords Science ; Q
    Language English
    Publishing date 2017-09-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top